Synthesis and Discovery of Estra-1,3,5(10),6,8-pentaene-2,16α-diol
journal contributionposted on 14.09.2018 by HtooTint Wai, Kang Du, Jason Anesini, Wan Shin Kim, Alan Eastman, Glenn C. Micalizio
Any type of content formally published in an academic journal, usually following a peer-review process.
A metallacycle-centered approach to the assembly of partially aromatic synthetic steroids was investigated as a means to prepare a boutique collection of unique steroidal agents. The synthesis and discovery of estra-1,3,5(10),6,8-pentaene-2,16α-diol (VII) is described, along with structure–activity relationships related to its cytotoxic properties. Overall, VII was found to have a GI50 = 0.2 μg/mL (∼800 nM) in MDA-MB-231 human breast cancer cells, be an efficacious estrogen receptor agonist with potency for ERβ > ERα (ERβ EC50 = 21 nM), possess selective affinity to the cdc-2-like kinase CLK4 (Kd = 350 nM), and be phenotypically related to paclitaxel by an unbiased panel assessment.